Cipla Limited
Results, Financials & Updates

Cipla Limited is a global pharmaceutical company founded in 1935, operating with 46 manufacturing sites that produce over 50 dosage forms and more than 1,500 products. The company serves over 80 markets worldwide with core strengths across respiratory, anti-retrovirals, urology, cardiology, anti-infectives, and central nervous system segments. The company's revenue engines are anchored by its One-India business (comprising branded prescription, trade generics, and consumer health), North America operations focusing on complex generics and respiratory portfolios, One Africa spanning South Africa private and tender markets, and Emerging Markets and Europe.